ArticleTrials2020

Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).

Danni Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.